CFR – Code of Federal Regulations Title 21
CFR – Code of Federal Regulations Title 21
Category: Drug regulatory and guidelines
Guidelines for viable & non -viable counts in gmp areas (As per WHO,2011)
Manufacture of sterile pharmaceutical preparations, four grades of clean areas are distinguished as follows: Grade A: The local zone for high-risk operations, e.g. filling and making aseptic connections. Normally such conditions are achieved by using a unidirectional airflow workstation. Unidirectional air flow systems should provide a homogeneous air speed of 0.36–0.54 m/s (guidance value) at […]
Guide To Inspections Validation Of Cleaning Processes
I. INTRODUCTION This article is written to guide and design how to set up validation procedure, one must recognize that for cleaning validation, as with validation of other processes, there may be more than one way to validate a process. In the end, the test of any validation process is whether scientific data shows that […]
Brief Introduction Of ICH Guidelines
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is a project that brings together the regulatory authorities of Europe, Japan and the United States and experts from the pharmaceutical industry in the three regions to discuss scientific and technical aspects of pharmaceutical product registration. The purpose of […]
Major Drug Regulatory Agencies World Wide
Pharmaceutical companies and regulatory agencies work together to enhance patient safety when a medicine is first being studied (pre-approval) and after it becomes available to patients and their health care providers as a treatment option, following authorization by regulatory agencies (post-approval). Regulatory agencies are government or non-government authorities, responsible for oversight of the effectiveness, safety, […]